Abstract
Lowering of the plasma FFA level in intact fasted rats by infusion of nicotinic acid (NA) caused essentially complete ablation of insulin secretion (IS) in response to a subsequent intravenous bolus of arginine, leucine, or glibenclamide (as previously found using glucose as the beta-cell stimulus). However, in all cases, IS became supranormal when a high FFA level was maintained by co-infusion of lard oil plus heparin. Each of these secretagogues elicited little, if any, IS from the isolated, perfused "fasted" pancreas when tested simply on the background of 3 mM glucose, but all became extremely potent when 0.5 mM palmitate was also included in the medium. Similarly, IS from the perfused pancreas, in response to depolarizing concentrations of KCl, was markedly potentiated by palmitate. As was the case with intravenous glucose administration, fed animals produced an equally robust insulin response to glibenclamide regardless of whether their low basal FFA concentration was further reduced by NA. In the fasted state, arginine-induced glucagon secretion appeared to be independent of the prevailing FFA concentration. The findings establish that the essential role of circulating FFA for glucose-stimulated IS after food deprivation also applies in the case of nonglucose secretagogues. In addition, they imply that (i) a fatty acid-derived lipid moiety, which plays a pivotal role in IS, is lost from the pancreatic beta-cell during fasting; (ii) in the fasted state, the elevated level of plasma FFA compensates for this deficit; and (iii) the lipid factor acts at a late step in the insulin secretory pathway that is common to the action of a wide variety of secretagogues.
Full Text
The Full Text of this article is available as a PDF (191.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aguilar-Bryan L., Nichols C. G., Wechsler S. W., Clement J. P., 4th, Boyd A. E., 3rd, González G., Herrera-Sosa H., Nguy K., Bryan J., Nelson D. A. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science. 1995 Apr 21;268(5209):423–426. doi: 10.1126/science.7716547. [DOI] [PubMed] [Google Scholar]
- Balasse E. O., Ooms H. A. Role of plasma free fatty acids in the control of insulin secretion in man. Diabetologia. 1973 Apr;9(2):145–151. doi: 10.1007/BF01230695. [DOI] [PubMed] [Google Scholar]
- Chen S., Ogawa A., Ohneda M., Unger R. H., Foster D. W., McGarry J. D. More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic beta-cell signaling. Diabetes. 1994 Jul;43(7):878–883. doi: 10.2337/diab.43.7.878. [DOI] [PubMed] [Google Scholar]
- Crespin S. R., Greenough W. B., 3rd, Steinberg D. Stimulation of insulin secretion by long-chain free fatty acids. A direct pancreatic effect. J Clin Invest. 1973 Aug;52(8):1979–1984. doi: 10.1172/JCI107382. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Greenough W. B., 3rd, Crespin S. R., Steinberg D. Hypoglycaemia and hyperinsulinaemia in response to raised free-fatty-acid levels. Lancet. 1967 Dec 23;2(7530):1334–1336. doi: 10.1016/s0140-6736(67)90917-8. [DOI] [PubMed] [Google Scholar]
- Heinze E., Kleinert W., Voigt K. H. Insulin release in rats 1 and 5 days after hypophysectomy. Horm Res. 1981;14(4):243–249. doi: 10.1159/000179394. [DOI] [PubMed] [Google Scholar]
- Komatsu M., Schermerhorn T., Noda M., Straub S. G., Aizawa T., Sharp G. W. Augmentation of insulin release by glucose in the absence of extracellular Ca2+: new insights into stimulus-secretion coupling. Diabetes. 1997 Dec;46(12):1928–1938. doi: 10.2337/diab.46.12.1928. [DOI] [PubMed] [Google Scholar]
- Koyama K., Chen G., Wang M. Y., Lee Y., Shimabukuro M., Newgard C. B., Unger R. H. beta-cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy. Diabetes. 1997 Aug;46(8):1276–1280. doi: 10.2337/diab.46.8.1276. [DOI] [PubMed] [Google Scholar]
- Prentki M., Corkey B. E. Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes. 1996 Mar;45(3):273–283. doi: 10.2337/diab.45.3.273. [DOI] [PubMed] [Google Scholar]
- Prentki M., Vischer S., Glennon M. C., Regazzi R., Deeney J. T., Corkey B. E. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J Biol Chem. 1992 Mar 25;267(9):5802–5810. [PubMed] [Google Scholar]
- Stein D. T., Esser V., Stevenson B. E., Lane K. E., Whiteside J. H., Daniels M. B., Chen S., McGarry J. D. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest. 1996 Jun 15;97(12):2728–2735. doi: 10.1172/JCI118727. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stein D. T., Stevenson B. E., Chester M. W., Basit M., Daniels M. B., Turley S. D., McGarry J. D. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest. 1997 Jul 15;100(2):398–403. doi: 10.1172/JCI119546. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weinhaus A. J., Poronnik P., Tuch B. E., Cook D. I. Mechanisms of arginine-induced increase in cytosolic calcium concentration in the beta-cell line NIT-1. Diabetologia. 1997 Apr;40(4):374–382. doi: 10.1007/s001250050690. [DOI] [PubMed] [Google Scholar]